Internal Medicine, Medical Oncology · Fairfax, VA
NPI
1033438270
Since 2010
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
8081 Innovation Park Dr
Fairfax, VA, 22031
Phone (571) 472-4724
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
538 services
Medicare patients, 2024
282
Average age 74
Drug cost, 2024
$261K
867 prescriptions
Company payments, 2025
$43K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathleen K Harnden was code 99214 (office e&m - established), 195 times for 175 patients. In total Kathleen K Harnden billed 538 services in 13 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 195 | 175 | $69.73 | $14K |
| 99215 Office E&M - Established | Office | 144 | 69 | $106.90 | $15K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 114 | 96 | $13.76 | $1,568 |
| 99233 Hospital E&M - Subsequent | Facility | 39 | 25 | $96.59 | $3,767 |
| 99205 Office E&M - New | Office | 25 | 25 | $145.02 | $3,626 |
By year: 2022 $51K for 532 services; 2023 $55K for 564 services; 2024 $40K for 538 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kathleen K Harnden prescribed most often to Medicare patients was Letrozole, with 506 prescriptions and refills. In total Kathleen K Harnden wrote 867 Medicare prescriptions that cost $261K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 506 | 1,468 | 161 | $15K |
| Anastrozole Generic | 55 | 163 | 18 | $1,047 |
| Exemestane Generic | 43 | 109 | 18 | $7,305 |
| Tamoxifen Citrate Generic | 29 | 67 | Under 11 | $1,054 |
| Dexamethasone Generic | 21 | 27 | 13 | $369 |
| Eliquis Apixaban | 17 | 27 | Under 11 | $15K |
| Ondansetron Hcl Generic | 16 | 16 | 13 | $127 |
| Prochlorperazine Maleate Generic | 14 | 14 | 12 | $223 |
| Trazodone Hcl Generic | 12 | 29 | Under 11 | $264 |
| Duloxetine Hcl Generic | 12 | 14 | Under 11 | $118 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 12 | 12 | Under 11 | $148 |
| Olanzapine Generic | 11 | 16 | Under 11 | $90.23 |
Brand drugs: 30 claims; generic drugs: 837 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathleen K Harnden $43K ($43K in general payments such as food, travel and fees) from 8 companies. The largest payer was Daiichi Sankyo Inc. with $32K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.